Neither emtricitabine nor tenofovir inhibited in vitro drug metabolism mediated by any of the major human CYP450 isoforms involved in drug biotransformation.
2
The manufacturer has not studied the use of emtricitabine in people who are failing their current anti-HIV regimen or who have failed multiple regimens.
3
This medicine contains the active ingredient emtricitabine, which is a type of medicine called a nucleoside reverse transcriptase inhibitor.